129 related articles for article (PubMed ID: 30878882)
1. Tumor dormancy at bedside: A late awakening.
Demicheli R; Desmedt C; Piccart M; Biganzoli E
Breast; 2019 Jun; 45():61-63. PubMed ID: 30878882
[TBL] [Abstract][Full Text] [Related]
2. The current role of sentinel node biopsy in the treatment of breast cancer.
Grube BJ; Giuliano AE
Adv Surg; 2004; 38():121-66. PubMed ID: 15515617
[No Abstract] [Full Text] [Related]
3. Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy.
Demicheli R; Abbattista A; Miceli R; Valagussa P; Bonadonna G
Breast Cancer Res Treat; 1996; 41(2):177-85. PubMed ID: 8944336
[TBL] [Abstract][Full Text] [Related]
4. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
[TBL] [Abstract][Full Text] [Related]
5. "Axillary recurrences after sentinel lymph node biopsy: a multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients".
van Wely BJ; van den Wildenberg FJ; Gobardhan P; van Dalen T; Borel Rinkes IH; Theunissen EB; Wijsman JH; Ernst M; van der Pol CC; Madsen EV; Vles WJ; Wauters CA; de Wilt JH; Strobbe LJ
Eur J Surg Oncol; 2012 Oct; 38(10):925-31. PubMed ID: 22633152
[TBL] [Abstract][Full Text] [Related]
6. Is regional nodes radiotherapy an alternative to surgery?
Offersen BV; Nielsen HM; Overgaard M; Overgaard J
Breast; 2013 Aug; 22 Suppl 2():S118-28. PubMed ID: 24074772
[TBL] [Abstract][Full Text] [Related]
7. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
8. Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up.
Avril A; Le Bouëdec G; Lorimier G; Classe JM; Tunon-de-Lara C; Giard S; MacGrogan G; Debled M; Mathoulin-Pélissier S; Mauriac L;
Eur J Surg Oncol; 2011 Jul; 37(7):563-70. PubMed ID: 21665421
[TBL] [Abstract][Full Text] [Related]
9. Significance of axillary lymph node extranodal soft tissue extension and indications for postmastectomy irradiation.
Mignano JE; Zahurak ML; Chakravarthy A; Piantadosi S; Dooley WC; Gage I
Cancer; 1999 Oct; 86(7):1258-62. PubMed ID: 10506712
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of extracapsular invasion of axillary lymph nodes combined with peritumoral vascular invasion in patients with breast cancer.
Yajima R; Fujii T; Yanagita Y; Fujisawa T; Miyamoto T; Hirakata T; Tsutsumi S; Iijima M; Kuwano H
Ann Surg Oncol; 2015 Jan; 22(1):52-8. PubMed ID: 25059790
[TBL] [Abstract][Full Text] [Related]
11. Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer.
Beenken SW; Urist MM; Zhang Y; Desmond R; Krontiras H; Medina H; Bland KI
Ann Surg; 2003 May; 237(5):732-8; discussion 738-9. PubMed ID: 12724640
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy in Chinese patients with large operable breast cancer (≥4 cm): A decade's experience from a single institution.
Yang Y; He Y; Fan Z; Ouyang T
Breast; 2017 Dec; 36():20-24. PubMed ID: 28869832
[TBL] [Abstract][Full Text] [Related]
13. The impact of the size of nodal metastases on recurrence risk in breast cancer patients with 1-3 positive axillary nodes after mastectomy.
Harris EE; Freilich J; Lin HY; Chuong M; Acs G
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):609-14. PubMed ID: 22867892
[TBL] [Abstract][Full Text] [Related]
14. Interpreting Breast Cancer Survival Data by the Hazard Function: Remarkable Findings from Event Dynamics.
Demicheli R; Hrushesky W; Retsky M; Biganzoli E
Medicina (Kaunas); 2020 Sep; 56(9):. PubMed ID: 32932597
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of apex axillary invasion for locoregional recurrence and effect of postmastectomy radiotherapy on overall survival in node-positive breast cancer patients.
Kuru B; Camlibel M; Dinc S; Gulcelik MA; Alagol H
World J Surg; 2004 Mar; 28(3):236-41. PubMed ID: 14961194
[TBL] [Abstract][Full Text] [Related]
16. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
[TBL] [Abstract][Full Text] [Related]
17. Is SLN Biopsy Alone Safe in SLN Positive Breast Cancer Patients?
van la Parra RF; de Wilt JH; Mol SJ; Mulder AH; de Roos WK; Bosscha K
Breast J; 2015; 21(6):621-6. PubMed ID: 26391102
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence.
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Venkatesan V; Dar AR; Stitt L
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):541-50. PubMed ID: 9231678
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for breast cancer patients with T1-2 tumor and 1-3 positive axillary nodes treated using total mastectomy without radiotherapy.
Asaga S; Kinoshita T; Shiino S; Jimbo K; Takayama S
Breast J; 2019 Jan; 25(1):26-33. PubMed ID: 30414218
[TBL] [Abstract][Full Text] [Related]
20. Postoperative loco-regional radiation therapy for breast cancer patients with four or more involved lymph nodes or extracapsular extension.
Evron E; Barzily L; Rakowsky E; Ben-Baruch N; Sulkes J; Rizel S; Fenig E
Isr Med Assoc J; 2005 Jul; 7(7):439-42. PubMed ID: 16011059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]